Cargando…

Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients

Detalles Bibliográficos
Autores principales:	Espiño, M, Arteche-López, A, Medina, S, Muñoz-Calleja, C, Blanchard, M J, Alegre, A, López-Jiménez, F J, Villar, L M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543252/ https://www.ncbi.nlm.nih.gov/pubmed/28581457 http://dx.doi.org/10.1038/bmt.2017.97

Ejemplares similares

P900: INVOLVED/UNINVOLVED SERUM FREE LIGHT CHAIN RATIO IS A STRONGER PREDICTOR OF DIAGNOSTIC/RISK FACTORS IN LIGHT CHAIN COMPARED TO HEAVY CHAIN MONOCLONAL GAMMOPATHIES
por: Thorir Oskarsson, Jon, et al.
Publicado: (2023)

Multiple Myeloma With a Rare Presentation at Preserved Uninvolved Immunoglobulins
por: Soma, Shunsuke
Publicado: (2022)

Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma
por: Ravi, P, et al.
Publicado: (2017)

The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma
por: Sarı, Murat, et al.
Publicado: (2017)

Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
por: Koulieris, Efstathios, et al.
Publicado: (2012)

INDEPENDENT SYNTHESIS OF LIGHT AND HEAVY CHAINS : Quantitation of Light-Chain Production by Mouse Myeloma Variants
por: Laskov, Reuven, et al.
Publicado: (1974)

Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients
por: Michallet, M, et al.
Publicado: (2018)

Management of endophthalmitis while preserving the uninvolved crystalline lens
por: Townsend, Justin, et al.
Publicado: (2012)

Stress-Related Regulation Is Abnormal in the Psoriatic Uninvolved Skin
por: Bozó, Renáta, et al.
Publicado: (2021)

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
por: Lopez-Anglada, Lucia, et al.
Publicado: (2018)

NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi
por: Tschandl, Philipp, et al.
Publicado: (2013)

Biophysical and ultrasonographic changes in lichen planus compared with uninvolved skin()()
por: Yazdanparast, Taraneh, et al.
Publicado: (2018)

Biophysical and ultrasonographic changes in pityriasis rosea compared with uninvolved skin
por: Yazdanparast, Taraneh, et al.
Publicado: (2020)

Biophysical Measurements and Ultrasonographic Findings in Chronic Dermatitis in Comparison with Uninvolved Skin
por: Yazdanparast, Taraneh, et al.
Publicado: (2019)

The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
por: Ríos-Tamayo, Rafael, et al.
Publicado: (2021)

Abnormal Epidermal Barrier Recovery in Uninvolved Skin supports the Notion of an Epidermal Pathogenesis of Psoriasis
por: Ye, Li, et al.
Publicado: (2014)

RECOMBINATION OF HEAVY AND LIGHT CHAINS OF HUMAN γA-MYELOMA PROTEINS: FORMATION OF HYBRID MOLECULES AND CONFIGURATIONAL SPECIFICITY
por: Prendergast, Robert A., et al.
Publicado: (1966)

Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis
por: Sethi, Amit, et al.
Publicado: (2023)

Light Chain Myeloma Precipitating Cryoglobulinemic Vasculitis
por: Saeed, Bilal, et al.
Publicado: (2023)

Idiotypes of inulin-binding myeloma proteins localized to variable region light and heavy chains: genetic significance
Publicado: (1977)

Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients
por: Batinić, Josip, et al.
Publicado: (2015)

Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
por: Napodano, Cecilia, et al.
Publicado: (2023)

Papillary carcinoma in thyroglossal duct cyst with uninvolved thyroid. Case report and review of the literature
por: Pietruszewska, Wioletta, et al.
Publicado: (2014)

Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients
por: Ludwig, H, et al.
Publicado: (2013)

Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients
por: Ludwig, H, et al.
Publicado: (2013)

Splenic rupture secondary to amyloid light-chain (AL) amyloidosis associated with multiple myeloma
por: Buzalewski, Jarrod, et al.
Publicado: (2019)

Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin
por: Kay, AB, et al.
Publicado: (2014)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma
por: Suehara, Yasuhito, et al.
Publicado: (2017)

Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains
por: Wilhite, Dorian, et al.
Publicado: (2021)

Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
por: Lohavanichbutr, Pawadee, et al.
Publicado: (2012)

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
por: Medina, Alejandro, et al.
Publicado: (2020)

High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa.
por: Preston, S. R., et al.
Publicado: (1995)

Do Muscle Strength Deficits of the Uninvolved Hip and Knee Exist in Young Athletes Before Anterior Cruciate Ligament Reconstruction?
por: Hannon, Joseph, et al.
Publicado: (2017)

Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update
por: Ria, Roberto, et al.
Publicado: (2018)

Dynein Modifiers in C. elegans: Light Chains Suppress Conditional Heavy Chain Mutants
por: O'Rourke, Sean M, et al.
Publicado: (2007)

Youth Bullying and Suicide: Risk and Protective Factor Profiles for Bullies, Victims, Bully-Victims and the Uninvolved
por: Kwan, Ching, et al.
Publicado: (2022)

Lower-Neck Sparing Using Proton Therapy in Patients with Uninvolved Neck Nasopharyngeal Carcinoma: Is It Safe?
por: De Felice, Francesca, et al.
Publicado: (2022)

Crystalline podocytopathy and tubulopathy linked to kappa light chain deposits in a context of smoldering multiple myeloma
por: Eymieux, Sébastien, et al.
Publicado: (2021)

The clinical utility of serum free light chain and heavy/light chain assays in monitoring disease activity in patients with IgG myeloma after achieving a deep response
por: Shimizu, Kazuyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r0q19rn789t42nq1qc3fig6ev1